VerityRank
Back to Rankings
China Traditional Chinese Medicine Holdings Co. Limited
Brand VerifiedChina

China Traditional Chinese Medicine Holdings Co. Limited

China Traditional Chinese Medicine Holdings Co. Limited (China TCM) is the largest manufacturer of TCM concentrated granule formulations and medicinal herb slices in the world, operating as a core platform under Sinopharm Group. Listed on the Hong Kong Stock Exchange (0570.HK) and headquartered in Foshan, Guangdong, the company posted CNY 14.74 billion in revenue in 2025, a 10.7% decline caused by

ChinaEst. 199215,583CNY 14.74 billionListed - HKEX (0570.HK)Score 82

Core Business Areas

TCM formula granules, medicinal herb slices, decoction pieces, herbal powders, prescription TCM, pharmaceutical distribution

Industry Rankings

VerityRank Score

82/ 100

Based on market presence, financial scale, operational capacity, and brand strength.

Quick Facts

Headquarters

Foshan, Guangdong / Hong Kong

Founded

1992

Employees

15,583

Listing

Listed - HKEX (0570.HK)

Categories

Traditional Chinese Medicine & Health Products Brands

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website , China TCM 2025 Annual Report - Minichart, Annual Results 2025 - HKEXnews, VBP Impact Analysis - HKEXnews